IN2015DN02358A - - Google Patents

Download PDF

Info

Publication number: IN2015DN02358A
Authority: IN; India
Prior art keywords: medicaments; cosmetics; synthesis; subject; formula
Prior art date: 2012-10-09

Application number

Other languages

English (en)

Inventor

Pietro Antonino; Di

Francesca; Cavazza

Paolo; Caliceti

Original Assignee

Sigma Tau Ind Farmaceuti

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-10-09

Filing date

2013-10-07

Publication date

2015-09-04

2013-10-07 Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti

2015-09-04 Publication of IN2015DN02358A publication Critical patent/IN2015DN02358A/en

Links

KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000003786 synthesis reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Polymers & Plastics (AREA)
Materials Engineering (AREA)
Birds (AREA)
Biochemistry (AREA)
Gerontology & Geriatric Medicine (AREA)
Food Science & Technology (AREA)
Mycology (AREA)
Nutrition Science (AREA)
Pulmonology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Otolaryngology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)

IN2358DEN2015 2012-10-09 2013-10-07 IN2015DN02358A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP12187828		2012-10-09
PCT/EP2013/070814 WO2014056841A1 (fr)	2012-10-09	2013-10-07	Dérivés d'acide hyaluronique modifiés et leur utilisation

Publications (1)

Publication Number	Publication Date
IN2015DN02358A true IN2015DN02358A (fr)	2015-09-04

Family

ID=47022522

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN2358DEN2015 IN2015DN02358A (fr)	2012-10-09	2013-10-07

Country Status (21)

Country	Link
US (1)	US20150252120A1 (fr)
EP (1)	EP2906193B1 (fr)
JP (1)	JP2015533190A (fr)
KR (1)	KR20150065861A (fr)
CN (1)	CN104703583A (fr)
AR (1)	AR092922A1 (fr)
AU (1)	AU2013328842A1 (fr)
BR (1)	BR112015007823A2 (fr)
CA (1)	CA2886144A1 (fr)
CL (1)	CL2015000803A1 (fr)
EA (1)	EA201590708A1 (fr)
HK (1)	HK1210941A1 (fr)
IL (1)	IL238103A0 (fr)
IN (1)	IN2015DN02358A (fr)
MX (1)	MX2015004386A (fr)
PE (1)	PE20150713A1 (fr)
PH (1)	PH12015500585A1 (fr)
SG (1)	SG11201501992XA (fr)
TW (1)	TW201414478A (fr)
WO (1)	WO2014056841A1 (fr)
ZA (1)	ZA201503171B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI614005B (zh) *	2014-05-26	2018-02-11	National Taipei University Of Technology	水膠組合物的用途
DE102014016158A1 (de) *	2014-07-11	2016-01-14	Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh	Zusammensetzung zur Behandlung von Magenbeschwerden
CN108883056A (zh) *	2015-12-30	2018-11-23	亚历山大·维莱诺维奇·阿萨福夫	用于治疗外周关节、脊柱关节和/或结缔组织的细胞外基质元件的制剂、制造方法和用途
RU2625766C1 (ru) *	2016-07-19	2017-07-18	Александр Ливиевич Ураков	Средство для экстренного восстановления голоса при внезапной афонии
EP3770180A4 (fr) *	2018-03-22	2021-12-22	Mochida Pharmaceutical Co., Ltd.	Dérivé d'acide alginique lié à un composé anti-inflammatoire non stéroïdien
EP3793525A4 (fr) *	2018-05-16	2022-02-16	Emory University	Particules d'acide hyaluronique et de palladium et procédés de gestion du cancer ou d'états angiogéniques

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4716224A (en)	1984-05-04	1987-12-29	Seikagaku Kogyo Co. Ltd.	Crosslinked hyaluronic acid and its use
US4851521A (en)	1985-07-08	1989-07-25	Fidia, S.P.A.	Esters of hyaluronic acid
GB8713662D0 (en)	1987-06-11	1987-07-15	Skandigen Ab	Hyaluronic acid derivatives
US4839159A (en)	1988-02-08	1989-06-13	Topicarn, Inc.	Topical L-carnitine composition
IT1219587B (it)	1988-05-13	1990-05-18	Fidia Farmaceutici	Polisaccaridi carbossiilici autoreticolati
IT1251151B (it)	1991-08-05	1995-05-04	Fidia Spa	Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
US6129761A (en)	1995-06-07	2000-10-10	Reprogenesis, Inc.	Injectable hydrogel compositions
ATE273026T1 (de) *	1998-11-13	2004-08-15	Continental Projects Ltd	Komplexe von hyaluronic saure/carnitinen und pharmazeutische und kosmetische zusammensetzungen
EP1401875A4 (fr)	2001-05-04	2005-01-26	Univ Utah Res Found	Acide hyaluronique contenant des bioconjugues: administration ciblee de medicaments anticancereux dans des cellules cancereuses
ITMI20021666A1 (it)	2002-07-26	2004-01-26	Jasper Ltd Liability Co	Derivati dell'acido ialuronico
US20110027357A1 (en) *	2004-02-18	2011-02-03	Isaac Gilinski	Compositions and methods for timed release of water-soluble nutritional supplements
US20060134147A1 (en)	2004-12-21	2006-06-22	Avon Products, Inc.	Cosmetic compositions having carnitine creatinate and methods for using
CA2593064A1 (fr)	2004-12-30	2006-07-06	Novozymes Biopolymer A/S	Acide hyaluronique lie a un polymere d'un alphahydroxyacide
JP5047507B2 (ja) *	2005-09-30	2012-10-10	昭和電工株式会社	カルニチン誘導体及びその塩、皮膚外用剤ならびに化粧料
ITMI20052035A1 (it)	2005-10-26	2007-04-27	Professional Dietetics Srl	Composizioni farmaceutiche cicatrizzanti sotto forma di crema a base di amminoacidi e sodio ialuronato
EP1884231A1 (fr)	2006-08-01	2008-02-06	Auriga International S.A.	Composition cosmétique ou pharmaceutique contenant acide hyaluronique
AU2007353211B2 (en)	2007-05-11	2013-08-29	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Gel useful for the delivery of cosmetic active ingredients
JP2010528039A (ja)	2007-05-23	2010-08-19	アラーガン、インコーポレイテッド	被覆されたヒアルロン酸粒子
WO2010003797A1 (fr)	2008-07-09	2010-01-14	Novozymes Biopharma Dk A/S	Acide hyaluronique pour la cicatrisation cornéenne

2013
- 2013-10-07 EP EP13773263.2A patent/EP2906193B1/fr active Active
- 2013-10-07 HK HK15111712.7A patent/HK1210941A1/xx unknown
- 2013-10-07 SG SG11201501992XA patent/SG11201501992XA/en unknown
- 2013-10-07 BR BR112015007823A patent/BR112015007823A2/pt not_active IP Right Cessation
- 2013-10-07 CN CN201380052657.6A patent/CN104703583A/zh active Pending
- 2013-10-07 PE PE2015000465A patent/PE20150713A1/es not_active Application Discontinuation
- 2013-10-07 IN IN2358DEN2015 patent/IN2015DN02358A/en unknown
- 2013-10-07 MX MX2015004386A patent/MX2015004386A/es unknown
- 2013-10-07 EA EA201590708A patent/EA201590708A1/ru unknown
- 2013-10-07 CA CA2886144A patent/CA2886144A1/fr not_active Abandoned
- 2013-10-07 TW TW102136212A patent/TW201414478A/zh unknown
- 2013-10-07 AU AU2013328842A patent/AU2013328842A1/en not_active Abandoned
- 2013-10-07 US US14/433,539 patent/US20150252120A1/en not_active Abandoned
- 2013-10-07 JP JP2015535043A patent/JP2015533190A/ja active Pending
- 2013-10-07 AR ARP130103624A patent/AR092922A1/es unknown
- 2013-10-07 KR KR1020157011845A patent/KR20150065861A/ko not_active Withdrawn
- 2013-10-07 WO PCT/EP2013/070814 patent/WO2014056841A1/fr active Application Filing
2015
- 2015-03-17 PH PH12015500585A patent/PH12015500585A1/en unknown
- 2015-03-31 CL CL2015000803A patent/CL2015000803A1/es unknown
- 2015-04-01 IL IL238103A patent/IL238103A0/en unknown
- 2015-05-08 ZA ZA2015/03171A patent/ZA201503171B/en unknown

Also Published As

Publication number	Publication date
JP2015533190A (ja)	2015-11-19
AR092922A1 (es)	2015-05-06
EP2906193B1 (fr)	2016-09-28
TW201414478A (zh)	2014-04-16
CN104703583A (zh)	2015-06-10
ZA201503171B (en)	2016-11-30
CL2015000803A1 (es)	2015-08-07
IL238103A0 (en)	2015-05-31
EA201590708A1 (ru)	2015-07-30
US20150252120A1 (en)	2015-09-10
PE20150713A1 (es)	2015-05-16
PH12015500585A1 (en)	2015-05-04
BR112015007823A2 (pt)	2017-07-04
KR20150065861A (ko)	2015-06-15
HK1210941A1 (en)	2016-05-13
MX2015004386A (es)	2015-06-10
WO2014056841A1 (fr)	2014-04-17
AU2013328842A1 (en)	2015-04-09
SG11201501992XA (en)	2015-04-29
CA2886144A1 (fr)	2014-04-17
EP2906193A1 (fr)	2015-08-19

Publication	Publication Date	Title
UA116648C2 (uk)	2018-04-25	Фумарати як проліки та їх застосування при лікуванні різних захворювань
GB201106743D0 (en)	2011-06-01	Novel compounds
MX2015008627A (es)	2015-09-23	Derivados de acido boronico y usos terapeuticos de los mismos.
PH12013501600A1 (en)	2013-09-30	Novel heterocyclic derivatives
PH12015501083B1 (en)	2015-08-03	Novel pyridine derivatives
NZ603151A (en)	2013-10-25	N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives
PH12014501514A1 (en)	2014-10-08	New azetidine derivatives, pharmaceutical compositions and uses thereof
MY179412A (en)	2020-11-05	Pyridine-2-amides useful as cb2 agonists
IN2015DN01119A (fr)	2015-06-26
IN2015DN03998A (fr)	2015-10-02
IN2014DN06104A (fr)	2015-08-14
MY182328A (en)	2021-01-19	Pyridine-2-amides useful as cb2 agonists
MX2015004362A (es)	2015-12-08	Derivados de ketamina.
PH12015500585A1 (en)	2015-05-04	Modified hyaluronic acid derivatives and use thereof
IN2014DN10449A (fr)	2015-08-21
MX2014004920A (es)	2014-05-28	Nuevos derivados de pirazina.
TR201903918T4 (tr)	2019-04-22	Bir dağıtım ajanı içeren bileşimler ve bunların hazırlanması.
MX2012010127A (es)	2013-01-29	Derivados de aminoindanos, su preparacion y su aplicacion en terapeuticos.
WO2011107866A3 (fr)	2011-12-29	Dérivés silyliques de polysaccharides
MX2014004210A (es)	2014-05-28	Derivados de 2-oxo-piperidinilo.
MX365192B (es)	2019-05-23	Derivados de bendamustina y compuestos relacionados, y uso medico de los mismos para la terapia de cancer.
MX348841B (es)	2017-06-30	Derivados de pirimidooxazocina como inhibidores de mtor.
PH12015500262A1 (en)	2015-03-30	Novel pyridine derivatives
IN2015MN00091A (fr)	2015-10-16
MX351093B (es)	2017-10-02	Nuevos derivados de azetidina.